Parkinson-like features in ALS with predominant upper motor neuron involvement

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 1, 2012, Pages 137-143

  D'Ascenzo, Carla ^a   Cecchin, Diego ^a   Santelli, Luca ^a   Palmieri, Arianna ^a   Gaiani, Alessandra ^a   Querin, Giorgia ^a   Cima, Valentina ^a   Volpe, Marco ^a   Bello, Luca ^a   Bui, Franco ^a   Cagnin, Annachiara ^a   Angelini, Corrado ^a   Pegoraro, Elena ^a   Sorar, Gianni ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; DatScan; Nigrostriatal system; Upper motor neuron

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BERG BALANCE SCALE; BRADYKINESIA; CLINICAL ARTICLE; DIAGNOSTIC TEST; DISEASE DURATION; DRUG UPTAKE; ELECTROMYOGRAM; EXTRAPYRAMIDAL SYSTEM; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MOTONEURON; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; PARKINSONISM; POSTURAL INSTABILITY; PRIORITY JOURNAL; PYRAMIDAL TRACT; RIGIDITY; SPASTICITY; UNIFIED PARKINSON DISEASE RATING SCALE; UPPER MOTOR NEURON; VELOCITY DEPENDENT STRETCH RESPONSE TEST; VESTIBULAR DISORDER;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; PARKINSON DISEASE; RETROSPECTIVE STUDIES;

EID: 84855395145     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.603732     Document Type: Article

References (30)

1. van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extramotor neuron involvement in amyo-trophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009;19:53-8.
2. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130-3. (Pubitemid 44547757)
3. Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyo-trophic lateral sclerosis. Arch Neurol. 2008;65:636-41. (Pubitemid 351679659)
4. Burrow JN, Blumbergs PC. Substantia nigra degeneration in motor neuron disease: a quantitative study. Aust N Z J Med. 1992;22:469-72.
5. Qureshi AI, Wilmot G, Dihenia B, Schneider JA, Krendel DA. Motor neuron disease with Parkinsonism. Arch Neurol. 1996;53:987-91. (Pubitemid 26340033)
6. Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neurpathol Appl Neurobiol. 1993;19:300-4. (Pubitemid 23237480)
7. Klos KJ, Josesphs KA, Parisi JE, Dickson DW. Alpha-synu-clein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease. Mov Disord. 2005;20:1515-20. (Pubitemid 43072663)
8. Imamura A, Wszolek Z, Uitti R. Neurodegenerative overlap syndrome: Parkinsonism and motor neuron disease. Mov Disord. 2007;22:151-2. (Pubitemid 46382696)
9. Mackenzie IR, Feldman H. Extrapyramidal features in patients with motor neuron disease and dementia; a clinico-pathological correlative study. Acta Neuropathol. 2004;107: 336-40. (Pubitemid 38477360)
10. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG. Parkinson-ism in MND: case report and literature review. Acta Neu-ropathol. 1995;89:275-83.
11. Uitti RJ, Berry K, Yasuhara O, Eisen A, Feldman H, McGeer PL, et al. Neurodegenerative ' overlap'syndrome: clinical and pathological features of Parkinson's disease, motor neuron disease and Alzheimer's disease. Parkinsonism Relat Disord. 1995;1:21-34.
12. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 1993; 342:1016-8. (Pubitemid 23314803)
13. Borasio GD, Linke R, Schwarz J, Schlamp V, Abel A, Mozley PD, et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with I-123 IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry. 1998;65:263-5. (Pubitemid 28371945)
14. Hideyama T, Momose T, Shimizu J, Tsuji S, Kwak S. A positron emission tomography study on the role of nigral lesions in Parkinsonism in patients with amyotrophic lateral sclerosis. Arch Neurol. 2006;63:1719-22. (Pubitemid 44925079)
15. Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain. 2001;124:1989-99. (Pubitemid 32958516)
16. Mabuchi N, Watanabe H, Atsuta N, Hirayama M, Ito H, Fukatsu H, et al. Primary lateral sclerosis presenting Parkinsonian symptoms without nigrostriatal involvement. J Neurol Neurosurg Psychiatry. 2004;75:1768-71. (Pubitemid 39611485)
17. Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. The natural history of primary lateral sclerosis. Neurology. 2006;66:647-53. (Pubitemid 43739816)
18. Norlinah IM, Bhatia KP, Ostergaard K, Howard R, Arabia G, Quinn N. Primary lateral sclerosis mimicking atypical Parkinsonism. Mov Disord. 2007;22:2057-62.
19. Gilbert RMW, Fahn S, Mitsumoto H, Rowland LP. Parkin-sonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Mov Disord. 2010;25:1868-75.
20. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The alsfrs-r: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13-21. (Pubitemid 29502501)
21. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner. 1964;192:540-2.
22. Broberg C, Grimby G. Measurement of torque during passive and active ankle movements in patients with muscle hypertonia: a methodological study. Scand J Rehabil Med Suppl. 1983;9:108-17. (Pubitemid 14135055)
23. Webster DD. Rigidity in extrapyramidal disease. J Neuro-surg. 1966;24:299-307.
24. Berg K, Wood-Dauphinee S, Williams JI. The Balance Scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med. 1995;27: 27-36.
25. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Mardsen CD, Calne D, editors. Recent development in Parkinson's disease. New Jersey: MacMillian Healthcare Information; 1987. p. 153-63.
26. Kagi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81:5-12.
27. Fleming JS, Bolt L, Stratford JS, Kemp PM. The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol. 2004;49:227-34.
28. Pradat PF, Bruneteau G, Munerati E, Salachas F, Le Forestier N, Lacomblez L,et al. Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov Disord. 2009;24:2143-8.
29. Sorar ù G, Ermani M, Logroscino G, Palmieri A, D'Ascenzo C, Orsetti V, et al. Natural history of upper motor neuron-dominant ALS. Amyotroph Lateral Scler. 2010;11:424-9.
30. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Special report. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol. 1997;41:706-15. (Pubitemid 27249175)